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Abstract: Caffeine intake, a frequent lifestyle exposure, has a number of biological effects. We designed
a cohort study to investigate the relation between lifestyle and assisted reproduction technique
(ART) outcomes. From September 2014 to December 2016, 339 subfertile couples referring to an
Italian fertility clinic and eligible for ART procedures were enrolled in our study. Sociodemographic
characteristics, smoking, and usual alcohol and caffeine consumption in the year prior to ART were
recorded. The mean age of participants was 36.6 ± 3.6 years in women and 39.4 ± 5.2 years in
men. After oocytes retrieval, 293 (86.4%) underwent implantation, 110 (32.4%) achieved clinical
pregnancy, and 82 (24.2%) live birth. Maternal age was the main determinant of ART outcome. In a
model including women’s age and college degree, smoking habits, calorie and alcohol intake for
both partners, previous ART cycles, and partner’s caffeine intake, we did not observe any association
between caffeine intake and ART outcome. Using the first tertile of caffeine intake by women as a
reference, the adjusted rate ratio (ARR) for live birth was 1.09 (95% confidence interval (CI) 0.79–1.50)
in the second and 0.99 (95% CI 0.71–1.40) in the third tertiles. In conclusion, a moderate caffeine
intake by women and men in the year prior to the ART procedure was not associated with negative
ART outcomes.
Keywords: caffeine intake; assisted reproduction techniques; risk factors; implantation; clinical
pregnancy; live birth
1. Introduction
Caffeine Intake is Among the Most Common Lifestyle Exposure in Women and Men Alike
Caffeine (1,3,7-trimethylxanthine) is found in coffee, tea, soft drinks (particularly cola-containing
beverages and energy drinks), and chocolate. It easily crosses biologic membranes, is rapidly
distributed throughout the body, and has been found in saliva, breast milk, the embryo, and the
neonate [1]. The caffeine molecule is easily absorbed by humans, having approximately 100%
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bioavailability when taken by oral route and reaching a peak in the blood within 15–45 min after
its consumption [2]. Caffeine has a number of biologic effects, including central nervous system
stimulation, increased secretion of catecholamine, relaxation of smooth muscles, and stimulation of
heart rate. Caffeine can also reach the follicular fluid, suggesting that it might exert a harmful role on
the female reproductive process [3].
During the last decades, the relation between lifestyle factors and spontaneous fertility has been
investigated in several observational studies, but, with regard to caffeine intake, few studies have
analyzed the association between caffeine intake and in vitro fertilization (IVF) outcomes, showing
inconsistent results. One study observed a negative association with live birth, when comparing
women consuming >2–50 and >50 versus <2 mg/day of caffeine in the year prior to IVF [4], while other
studies found no association between caffeine intake consumed just before or during IVF treatment
and IVF outcomes [5,6]. In a study conducted in Boston [7], the adjusted percentage of cycles resulting
in live birth for women in increasing categories of caffeine intake was 46% for <50 mg/day, 44%, 42%, 40%
in intermediate intake categories, and 40% for >300 mg/day. On the other hand, Karmon et al. [8] recently
found that caffeine intake was associated with a lower probability of achieving live birth after assisted
reproduction techniques (ART), although this inverse association was limited to intracytoplasmic
sperm injection (ICSI) cycles.
Thus, limited and conflicting data are available on the relation between caffeine intake and ART
outcomes. In this paper, we analyzed the role of male and female caffeine consumption in ART
outcomes, using data from a cohort study conducted in an Italian fertility center.
2. Methods
From September 2014 to December 2016, on randomly selected days, subfertile couples presenting
for evaluation to the Fertility Unit of Fondazione IRCCS Ca’ Granda, Ospedale Maggiore, Policlinico,
Milan, and eligible for assisted reproduction technologies (ART), were invited to participate in an
ongoing prospective cohort study on the role of lifestyle habits and diet on ART outcome. The study
protocol was approved by the Ethical Review Board of Fondazione IRCCS Ca’ Granda, Ospedale
Maggiore, Policlinico (Milan, Italy). All procedures were conducted in accordance with the Helsinki
Declaration and all participants provided written informed consent.
Study participation was proposed during the diagnostic phase. Couples were interviewed on the
day of oocyte retrieval. On the same day, a semen sample was also collected and analyzed to proceed
with in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). The time interval between
the proposal of the study and the interview was generally less than one month. In the early period
only women were interviewed, whereas partners’ information collection started at a later stage.
Both partners of couples who agreed to participate were interviewed by centrally trained
personnel, using a standard questionnaire to obtain information on general sociodemographic
characteristics, personal and health history and habits (including smoking, physical activity, alcohol
intake, and methylxanthine-containing beverages consumption). Couples who did not speak fluent
Italian were excluded.
The overall participation rate was close to 95%. This high participation rate was mainly due to
the fact that couples were interviewed during the period spent waiting for the different diagnostic
stages, before the actual ART procedure. Considering this down time and the not sensitive character
questions, couples did not usually refuse to answer the questionnaire.
The questionnaire included information on sociodemographic characteristics, anthropometric
variables, and lifestyle factors—including tobacco smoking, alcohol and caffeine intake, and diet
habits—as well as a problem-oriented personal medical history and reproductive history.
Information on diet was based on a reproducible and validated food frequency questionnaire
(FFQ), including 78 foods, food groups (such as the major sources of animal fats (i.e., red meat, milk,
cheese, ham, salami), folates, vitamins (vegetables and fruit), pasta and bread consumption, cake,
sweets and chocolate, fish), and the most common Italian recipes [9–11]. Patients were asked to
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report their usual weekly food consumption in the last year. The FFQ includes the average weekly
consumption of 78 food items or food groups. Energy and mineral, macro-, and micronutrient intakes
were estimated using the most recent update of an Italian food consumption database [12].
The weekly numbers of drinks for several alcoholic beverages were elicited from the subjects.
Taking into account the different ethanol concentrations, one drink corresponded to approximately 125 mL
of wine, 330 mL of beer, and 30 mL of hard liquor (i.e., about 12.5 g of ethanol). Total alcohol intake,
expressed in grams of ethanol per day (g/day), was computed as the sum of all reported alcoholic
beverages. “Never drinkers” were patients who abstained from drinking lifelong; “ex-drinkers” were
individuals who had abstained from drinking for at least 12 months at the time of interview. For the
purpose of this study, we considered these subjects in the category “abstainers”.
Further, questions included information on coffee and other methylxanthine-containing beverages
(tea, cocoa, and decaffeinated coffee), and the average number of cups per day. Caffeine intake from
coffee (60 mg per cup), cappuccino (75 mg per cup), tea (45 mg per cup), decaffeinated coffee (4 mg
per cup), and chocolate (6 mg/10 g) was calculated [13].
A subject was considered a smoker if she had smoked more than one cigarette/day for at least
one year; an ex-smoker if she had smoked more than one cigarette/day for at least one year, but had
stopped more than one year before the interview, and a non-smoker if she had never smoked more
than one cigarette/day.
Satisfactory reproducibility of questions on self-reported smoking and drinking habits in our
study populations has been previously reported [14].
Patients were managed according to a standardized clinical protocol, as reported in detail
elsewhere [15]. Couples underwent ART with conventional IVF or ICSI as clinically indicated.
Serum hCG assessment to detect pregnancy was performed 14 or 16 days after ovulation triggering
or luteinizing hormone (LH) surge. Women with positive human corionic gonadotropin (hCG) values
underwent a transvaginal sonography three weeks later. Clinical pregnancy was defined as the
presence of at least one intrauterine gestational sac.
All clinical information (including infertility diagnoses) was collected from medical records.
Statistical Analysis
Multiple outcomes were considered in this analysis: (1) number of retrieved high quality oocytes;
(2) undergoing embryo transfer (implantation); (3) clinical pregnancy; (4) live birth.
Categorical variables were described as frequency (N) and percentage (%) and compared using the
Pearson or Mantel-Haenzsel (MH) chi-square, as appropriate. Continuous variables were described as
means with standard deviation (SD) if normally distributed, or medians and interquartile ranges (IQR)
if not normally distributed. Univariate analyses used were analysis of variance and Kruskal-Wallis test.
The correlation between male and female caffeine consumption was evaluated by means of Spearman
correlation rho, because caffeine consumption was not normally distributed.
In the multivariable models, we included as potential confounders variables associated with
caffeine intake or ART outcomes at the univariate analysis. Thus, we accounted for women’s age,
education, tobacco smoking, alcohol intake, total energy intake, and previous ART cycles.
As regards the oocyte number, it was square-root transformed and included in a general
linear equation with the aforementioned variables. We calculated the adjusted means in tertiles
of women’s caffeine intake, and according to its 95% confidence intervals (CIs). Then, these figures
were back-transformed to medians and 95% CIs.
Using unconditional multiple logistic regression, we estimated rate ratios (RR) of each outcome
and corresponding 95% CIs in categories of caffeine intake (approximate tertiles). In the logistic
regression equation, we included woman’s age, education, tobacco smoking, alcohol intake, total
energy intake, and previous ART cycles. As regards men’s variables, we included alcohol and calorie
intake. Furthermore, we mutually adjusted men’s and women’s caffeine intake. In a second model,
we combined categories of intake under and over the median (for each sex) and, using the lowest
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category (both the woman’s and partner’s intake under the median) as the reference, we calculated the
RRs for ART failure in the other three groups.
Statistical significance was set at p < 0.05. All analyses were performed using SAS software,
version 9.4 (SAS Institute, Inc., Cary, NC, USA).
3. Results
From September 2014 to December 2016, 501 women and 347 men were interviewed; since
eight men did not provide complete information, the couples were excluded from the analysis.
The final analysis included 339 couples, who provided complete information about their lifestyle and
coffee/caffeine intake and underwent an ART cycle.
As regards women, the mean age was 36.6 years (standard deviation, SD, 3.6, range 27–45) and
the mean body mass index (BMI) was 22.2 kg/m2 (SD 3.7, range 17.0–41.0); 18 (5.4%) women were
obese (BMI > 30.0 kg/m2). As regards men, the mean age was 39.4 years (SD 5.2, range 27–60) and the
mean BMI was 25.3 kg/m2 (SD 3.0); 29 (8.8%) men were obese.
Table 1 shows the characteristics of women and men according to caffeine intake. There was no
difference in terms of age, education, BMI, or cause for infertility in tertiles of caffeine consumption.
A relationship was observed with smoking habits and alcohol intake both in men (chi-square p = 0.001
and 0.02, respectively) and women (chi-square p = 0.002 and 0.01, respectively). Women who had
undergone previous ART cycles were more frequently in the lowest caffeine intake tertile (p = 0.002).
Both men’s and women’s total energy intake increased by tertiles of caffeine consumption (p < 0.0001).
The correlation between male and female caffeine intake was statistically significant (p = 0.0002)
but not very high (Spearman rho = 0.20).
After oocytes retrieval, 293 (86.4%) underwent embryo-transfer, 110 (32.4%) achieved clinical
pregnancy, and 82 (24.2%) experienced a live birth, including eight twin births. Out of 28 interrupted
clinical pregnancies, 27 were miscarriages and one was an induced abortion.
ART outcomes were not associated with any men’s characteristics, whereas women’s education
was significantly related to implantation (RR for college degree 1.78, 95% CI 1.00–3.18) and age at
clinical pregnancy (for women aged: 35–40 years, RR 1.11, 95% CI 0.80–1.54; ≥40 years, RR 1.80, 95%
CI 1.09–2.98; chi-square for trend 5.05, p = 0.025) and live birth (for women aged: 35–39 years, RR
1.30, 95% CI 0.88–1.93; ≥40, RR 2.43, 95% CI 1.28–4.63; chi-square for trend 7.93, p = 0.005). In both
outcomes, older women were at a higher risk of failure. At univariate analysis, no association was
observed with men’s or women’s caffeine intake.
Mean gestational week at delivery was 39.2 (SD 1.9, range 34–42); this was not associated with
maternal caffeine intake, either as a continuous variable or in tertiles (Spearman rho = 0.19, p = 0.09).
Mean gestational age in tertile of maternal intake was 39.0 (SD 1.7), 39.4 (SD 2.0), and 39.3 (SD 2.1) in
the first, second, and third tertiles, respectively. Excluding twins, mean birth weight was 3140 (SD 428),
with no significant differences across groups of maternal caffeine intake.
Table 2 shows the adjusted number of retrieved oocytes, adjusted for women’s age, education,
smoking habits, and calorie and alcohol intake. Adjusted median number of oocytes was higher in the
third tertile of caffeine intake, but this difference was not statistically significant.
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Table 1. Demographic characteristics of 339 couples, according to caffeine intake.
Women Men
First Tertile Second Tertile Third Tertile First Tertile Second Tertile Third Tertile
0–86 mg/day 87–180 mg/day 181–480 mg/day 0–124 mg/day 125–209 mg/day 210–560 mg/day
n = 114 33.6% n = 116 34.2% n = 109 32.1% n = 112 33.1% n = 113 33.3% n = 114 33.6%
Daily Caffeine Intake (mg/day),
Median (IQR) 37 14–60 128 111–147 215 188–255 62 17–100 180 154–189 258 231–310
Age (years)
<35 31 27.2 33 28.4 36 33.0 19 17.0 25 22.1 25 21.9
35–39 60 52.6 51 44.0 52 47.7 39 34.8 43 38.0 42 36.8
≥40 23 20.2 32 27.6 21 19.3 54 48.2 45 39.8 47 41.2
College Degree 62 54.4 67 57.8 53 48.6 42 37.5 42 37.2 51 44.7
Cause of Infertility
Unexplained 23 20.2 31 26.7 16 14.7 25 22.3 23 20.4 22 19.3
Female factor only 48 42.1 42 36.2 41 37.6 42 37.5 45 39.8 44 38.6
Male and female factor 43 37.7 43 37.1 52 47.7 45 40.2 45 39.8 48 42.1
BMI
<18.5 12 10.5 4 3.5 12 11.0 - - - - - -
18.5–24.9 82 71.9 86 76.1 78 71.6 46 45.1 55 48.7 45 39.5
25.0–29.9 17 14.9 13 11.5 14 12.8 48 47.1 48 42.5 58 50.9
≥30.0 3 2.6 10 8.8 5 4.6 8 7.8 10 8.8 11 9.6
Smoking Habits
Never 74 64.9 72 62.1 49 45.0 55 53.4 46 40.7 28 24.8
Current 15 13.2 15 12.9 34 31.2 24 23.3 33 29.2 50 44.2
Former 25 21.9 29 25.0 26 23.8 24 23.3 34 30.1 35 31.0
Alcohol Intake
Abstainer 40 35.1 33 28.4 23 21.1 14 13.6 9 8.0 8 7.0
<1 unit/day 72 63.2 75 64.7 73 67.0 57 55.3 66 58.4 53 46.5
≥1 unit/day 2 1.7 8 6.9 13 11.9 32 31.1 38 33.6 53 46.5
Leisure Physical Activity
<2 h/week 57 50.0 66 57.4 69 63.3 36 35.3 48 42.9 49 43.8
2–4 44 38.6 43 37.4 32 29.4 37 36.3 44 39.3 38 33.9
>4 13 11.4 6 5.2 8 7.3 29 28.4 20 17.9 25 22.3
Previous ART Cycle 81 71.0 60 51.7 54 49.5 67 59.8 63 58.4 62 54.4
Daily Calories Intake (Kcal/day),
Median (IQR) 1589 1367–1924 1748 1497–2124 1871 1602–2179 1781 1480-2060 1960 1649–2262 2122 1753–2407
Sometimes the sums do not add up to the totals because of missing values. Bold: p < 0.05, IQR: median and interquartile range; BMI: body mass index.
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Table 2. Rate ratios for failure of assisted reproduction technique (ART) outcomes.
Number of
High-Quality
Oocytes (Adjusted *
Median, 95% CI)
Implantation ARR(95% CI) Clinical Pregnancy ARR (95% CI) Live Birth ARR (95% CI)
Failure
n = 46
(13.6%)
Success
n = 293
(86.4%)
Failure
n = 229
(67.6%)
Success
n = 110
(32.4%)
Failure
n = 257
(75.8%)
Success
n = 82
(24.2%)
Women
Caffeine intake n % n % n % n % n % n %
First tertile 4.8 (4.0–5.7) 14 30.4 100 34.1 1 74 32.3 40 36.4 1 84 32.7 30 36.6 1
Second tertile 4.6 (3.9–5.4) 20 43.5 96 32.8 1.34 (0.64–2.79) 84 36.7 32 29.1 1.07 (0.76–1.50) 95 37.0 21 25.6 1.09 (0.79–1.50)
Third tertile 5.3 (4.5–6.1) 12 26.1 97 33.1 0.90 (0.38–2.10) 71 31.0 38 34.6 1.00 (0.70–1.43) 78 30.3 31 37.8 0.99 (0.71–1.40)
>90 percentile § 5.1 (3.8–6.7) 5 10.9 29 9.9 0.58 (0.16–2.04) 23 10.0 11 10.0 0.96 (0.51–1.80) 24 9.3 10 12.2 0.99 (0.54–1.84)
Men
Caffeine intake
First tertile - 12 26.1 100 34.1 1 71 31.0 41 37.3 1 83 32.3 29 35.4 1
Second tertile - 22 47.8 91 31.1 1.64 (0.78–3.44) 76 33.2 37 33.6 1.01 (0.72–1.42) 88 34.2 25 30.5 1.02 (0.75–1.41)
Third tertile - 12 34.8 102 34.8 0.78 (0.32–1.87) 82 35.8 32 29.1 1.07 (0.76–1.52) 86 33.5 28 34.1 1.00 (0.72–1.40)
>90 percentile § - 4 8.7 35 12 0.73 (0.17–3.16) 27 11.8 12 10.9 1.12 (0.59–2.14) 29 11.3 10 12.2 0.98 (0.54–1.83)
Combined intake (W-M)
Low-low - 14 30.4 81 27.6 1 64 28.0 31 28.2 1 71 27.6 24 29.3 1
Low-high - 10 21.7 65 22.2 0.79 (0.34–1.85) 56 24.4 19 17.3 1.03 (0.71–1.50) 62 24.1 13 15.8 1.09 (0.76–1.55)
High-low - 12 26.1 61 20.8 1.22 (0.53–2.78) 48 21.0 25 22.7 0.95 (0.64–1.42) 57 22.2 16 19.5 1.06 (0.73–1.54)
High-high - 10 21.7 86 29.4 0.60 (0.24–1.48) 61 26.6 35 31.8 0.89 (0.61–1.30) 67 26.1 29 35.4 0.93 (0.65–1.33)
The final model included women’s age class and college degree, smoking habits, calorie and alcohol intake for both men and women, previous ART cycles, and partner’s caffeine intake.
ARR: adjusted rate ratio; CI: confidence interval; * for women’s age class and education, smoking habits, calorie and alcohol intake; § reference category: <10 percentile; W-M: women-men.
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RRs for caffeine intake, after adjusting for variables that were associated with caffeine intake
(smoking habits and alcohol intake, daily calories) or ART outcomes (women’s age and education),
was consistently higher in the intermediate class of women’s intake, but this findings were not
significant. Men’s caffeine consumption was also not statistically significant; no dose-effect was
suggested by the observed estimates.
We built a second model with four categories for combined couple’s caffeine intake (lower and
equal/higher than the median for their sex): using the group of lowest combined caffeine intake,
we did not find significant associations between the outcomes and different couples’ caffeine intake,
nor did we observe trends suggesting a relationship.
Performing the analysis in groups of procedure (IVF or ICSI), we did not find any marked
difference in the relationship between caffeine intake and ART outcomes (data not shown).
4. Discussion
This prospective study of couples undergoing IVF or ICSI found that caffeine intake by women,
men, and the couple was not associated with implantation, clinical pregnancy, and live birth, adjusting
for women’s age class and college degree, smoking habits, calorie and alcohol intake for both men and
women, and previous ART cycles. Similarly, caffeine consumption by women was not related to the
number of oocytes retrieved.
Potential limitations of this study should be considered. All information on lifestyle habits
was self-reported by the patients, so some underestimates may have occurred. However, in Italy,
recommendations to avoid caffeine in pregnancy have not received widespread attention and are not
routinely advocated by gynecologists before IVF or ICSI, and misreporting of this variable should
be unlikely.
Other sources of bias, including selection or confounding factors, are also unlikely to have
produced marked effects, especially considering that all subjects were interviewed in the same
institution and that participation was practically complete.
With regard to other biases, we analyzed information on nutritional status, and their inclusion into
the model did not change the estimated OR. Further, the questionnaire was satisfactorily reproducible:
correlation coefficients were >0.65 for most frequently eaten food, and between 0.50 and 0.65 for
others [16]. However, the exact amount of caffeine in caffeinated beverages is difficult to quantify.
Although patients reported the number of cups of caffeinated beverages that they drink, the exact
amount of milligrams of caffeine in a cup depends on the mix of the brew, how it is prepared, and the
size of the cup. The questionnaire also asked questions about soda, but did not discriminate between
caffeinated and non-caffeinated varieties. Although these factors are likely to underestimate the
caffeine intake, a differential bias is unlikely.
Another potential limitation is study power. For example, with our data we can identify an RR of
pregnancy loss for the third tertile of caffeine intake of about 1.8. Thus, our results cannot rule out
modest effect sizes, which we were underpowered and thus difficult to detect.
The strengths of our study include its prospective design with complete follow-up and our ability
to adjust for a wide range of potential confounders. We also obtained information on male partner
diet, alcohol intake, and smoking habits, which previous studies have not included.
We did not found any statistically significant association between caffeine intake and ART success.
Our findings are not consistent with those of Klonoff-Cohen et al. [4], who observed an association
between usual coffee intake and lower ART success rate in 221 couples undergoing IVF or gamete
intra-Fallopian transfer. This relationship was significant even in women reporting an intake of
20–50 mg caffeine/day, less than the equivalent of one cup of coffee per day. However, no association
was observed with intake in the week before or during the procedure, a fact that the authors ascribed
to the possibility that during the ART procedure women refrained from or decreased coffee drinking.
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In the study by Al-Saleh and colleagues [3], no relationship emerged between coffee consumption
and pregnancy outcomes, yet the authors observed a decrease in the number of eggs retrieved and an
increase in miscarriage frequency as caffeine intake increased.
On the contrary, a recent cohort study, including 300 women and 493 ART cycles, provided
reassurance that low to moderate intakes of caffeine (e.g., <200 mg/day) in the year prior to infertility
treatment initiation do not have an adverse effect on intermediate or clinical outcomes of ART [7].
Another recent study by Machtinger et al. [6] enrolled 340 women undergoing IVF from 2014 through
2016 and did not retrieve any association between coffee and caffeine consumption and ART outcomes,
whereas a threat to reproductive success was attributable to sugared beverages, independent of their
caffeine content.
Considering men’s caffeine intake as well, Choi et al. [5] found no relationship with implantation,
fertilization, or live birth in a cohort including 2474 couples and 4716 IVF cycles. Although higher
caffeine intake by women was associated with a significantly lower peak estradiol level, it was not
related to the number of oocytes retrieved, implantation, fertilization, or live birth rate.
In a survey conducted in Italy in 2005–2006 [17], 1245 women had a median caffeine intake of
116 mg/day (95th percentile 355 mg/day) and 1068 men had a median caffeine intake of 112 mg/day
(95th percentile 330 mg/day). In our sample, levels of consumption were similar in men, with a higher
median (180 mg/day) but a similar 95th percentile, but not in women, who showed a similar median
(126 mg/day) but a lower 95th percentile intake (272 mg/day). About 80% of women in our group
consumed less than 200 mg of caffeine, which is the limit that, according to the European Food Safety
Agency (EFSA), does not give rise to safety concerns for the fetus [18].
5. Conclusions
Our study does not show an effect of moderate coffee intake by women, men, or the couple
on oocyte quality and success rate after ART procedures. Considering that our sample represented
a moderate consumption of caffeine, as well as alcohol and tobacco, we cannot evaluate the effect
of higher intakes on IVF outcomes. Thus, conservatively, all women seeking pregnancy should be
advised to maintain caffeine intakes within limits suggested by the EFSA.
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